These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 277227)

  • 1. Effect of radiation on cis-dichlorodiammineplatinum (II) and DNA in aqueous solution.
    Richmond RC; Simic MG
    Br J Cancer Suppl; 1978 Jun; 3():20-3. PubMed ID: 277227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The radiation chemistry of some platinum-containing radiosensitizers and related compounds.
    Butler J; Hoey BM; Swallow AJ
    Radiat Res; 1985 Apr; 102(1):1-13. PubMed ID: 4039071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiation chemistry of cis-platinum-nucleotide complexes.
    Anastassopoulou JD; Brekoulakis JS
    Anticancer Res; 1990; 10(4):983-6. PubMed ID: 2166464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinum complexes as radiosensitizers of hypoxic mammalian cells.
    Douple EB; Richmond RC
    Br J Cancer Suppl; 1978 Jun; 3():98-102. PubMed ID: 277266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxic variability and radiation sensitization by dichlorodiammineplatinum(II) complexes in Salmonella typhimurium cells.
    Richmond RC
    Radiat Res; 1984 Sep; 99(3):596-608. PubMed ID: 6382408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of aqueous free radicals and cis-dichlorodiammineplatinum(II) on radiation-induced base release from DNA.
    Richmond RC; Kelman AD
    Radiat Res; 1981 Dec; 88(3):476-88. PubMed ID: 7031752
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and X-ray crystal structure of trans,cis-[Pt(OAc)2I2(en)]: a novel type of cisplatin analog that can be photolyzed by visible light to DNA-binding and cytotoxic species in vitro.
    Kratochwil NA; Zabel M; Range KJ; Bednarski PJ
    J Med Chem; 1996 Jun; 39(13):2499-507. PubMed ID: 8691447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxic variability and radiation sensitization by Pt(II) analogs in Salmonella typhimurium cells.
    Richmond RC; Khokhar AR; Teicher BA; Douple EB
    Radiat Res; 1984 Sep; 99(3):609-26. PubMed ID: 6382409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of oxidative DNA damage and DNA-crosslink formation induced by cis-diammine-tetrachloro-platinum(IV) in the presence of endogenous reductants.
    Nakai T; Ando M; Okamoto Y; Ueda K; Kojima N
    J Inorg Biochem; 2011 Jan; 105(1):1-5. PubMed ID: 21134595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.
    Malfoy B; Hartmann B; Macquet JP; Leng M
    Cancer Res; 1981 Oct; 41(10):4127-31. PubMed ID: 7197193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A photoactivated trans-diammine platinum complex as cytotoxic as cisplatin.
    Mackay FS; Woods JA; Moseley H; Ferguson J; Dawson A; Parsons S; Sadler PJ
    Chemistry; 2006 Apr; 12(11):3155-61. PubMed ID: 16470886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic studies of a novel class of trisubstituted platinum(II) antitumor agents.
    Hollis LS; Sundquist WI; Burstyn JN; Heiger-Bernays WJ; Bellon SF; Ahmed KJ; Amundsen AR; Stern EW; Lippard SJ
    Cancer Res; 1991 Apr; 51(7):1866-75. PubMed ID: 2004370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
    Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
    Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemistry of dinuclear analogues of the anticancer drug cisplatin. A DFT/CDM study.
    Deubel DV
    J Am Chem Soc; 2006 Feb; 128(5):1654-63. PubMed ID: 16448139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular pharmacology of liposomal cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexaneplatinum(II) in A2780/S and A2780/PDD cells.
    Han I; Ling YH; al-Baker S; Khokhar AR; Perez-Soler R
    Cancer Res; 1993 Oct; 53(20):4913-9. PubMed ID: 8402681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations using fluorescent ligands to monitor platinum(IV) reduction and platinum(II) reactions in cancer cells.
    New EJ; Duan R; Zhang JZ; Hambley TW
    Dalton Trans; 2009 Apr; (16):3092-101. PubMed ID: 19352538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation damage to DNA in aqueous solution: effects of radiosensitizers.
    Ward JF
    Br J Cancer Suppl; 1978 Jun; 3():42-5. PubMed ID: 277255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on cis-dichlorodiammineplatinum (II) as a radiosensitizer.
    Alvarez MV; Cobreros G; Heras A; Lopez Zumel MC
    Br J Cancer Suppl; 1978 Jun; 3():68-72. PubMed ID: 277260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of metallothionein-2 with platinum-modified 5'-guanosine monophosphate and DNA.
    Karotki AV; Vasák M
    Biochemistry; 2008 Oct; 47(41):10961-9. PubMed ID: 18803406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theoretical analysis on the transition state of the anticancer drug trans-[PtCl2(isopropylamine)2] and its cis isomer binding to DNA purine bases.
    Zhou L
    J Phys Chem B; 2009 Feb; 113(7):2110-27. PubMed ID: 19173577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.